Basic Information
Basic information for LINC01278-231-19aa-3
Peptide Name LINC01278-231-19aa-3
Genome Position chrX:63398883-63398939[-]
Species Human
Peptide Sequence MLSTDSWRSRTATLYFLSS
Peptide Length 19
Unique No (LINC01278-211-19aa-2,LINC01278-212-19aa-1,LINC01278-215-19aa-1,LINC01278-220-19aa-2,LINC01278-227-19aa-3)
Grand Average of Hydropathicity -0.1526
Relative Molecular Mass 2546.84
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000235437;LINC01278
Transcript ID/Name ENST00000669201;LINC01278-231
Transcript Length 2757
Coding Ability 0.3217
DNA Sequence Corresponding to Peptide ATGTTAAGCACGGACTCTTGGAGATCCAGGACAGCCACCTTGTACTTCCTGAGTTCT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :